New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patients

[News]

Canadian researchers develop a cell-free DNA-based multimodal assay for early cancer detection in patients with Li-Fraumeni Syndrome, a high-cancer-risk condition. The assay outperforms conventional methods, promising more sensitive and less invasive cancer surveillance.

More... (https://www.news-medical.net/news/20231029/New-blood-test-revolutionizes-early-cancer-detection-in-Li-Fraumeni-Syndrome-patients.aspx)